Organization | Peshawar Medical College

Peshawar Medical College Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2013

NCT01908114

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Alternative names

Peshawar Medical College

Active Ingredients

Drugs in Phase 4 Trials (2)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (1 trial)

polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Poliomyelitis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 1
# of Trial APIs: 2